Direkt zum Inhalt

Hutterer, Markus ; Nowosielski, Martha ; Haybaeck, Johannes ; Embacher, Sabine ; Stockhammer, Florian ; Gotwald, Thaddäus ; Holzner, Bernhard ; Capper, David ; Preusser, Matthias ; Marosi, Christine ; Oberndorfer, Stefan ; Moik, Martin ; Buchroithner, Johanna ; Seiz, Marcel ; Tuettenberg, Jochen ; Herrlinger, Ulrich ; Wick, Antje ; Vajkoczy, Peter ; Stockhammer, Günther

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)

Article

Hutterer, Markus, Nowosielski, Martha, Haybaeck, Johannes, Embacher, Sabine, Stockhammer, Florian , Gotwald, Thaddäus, Holzner, Bernhard, Capper, David, Preusser, Matthias , Marosi, Christine, Oberndorfer, Stefan, Moik, Martin, Buchroithner, Johanna, Seiz, Marcel, Tuettenberg, Jochen, Herrlinger, Ulrich, Wick, Antje, Vajkoczy, Peter and Stockhammer, Günther (2014) A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology 16 (1), pp. 92-102.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleNeuro-Oncology
PublisherOXFORD UNIV PRESS INC
Place of PublicationCARY
Volume16
Number of Issue or Book Chapter1
Page Rangepp. 92-102
Date2014
Date of publication24 Jan 2014 09:12
InstitutionsMedicine > Lehrstuhl für Neurologie
Identification Number
ValueType
10.1093/neuonc/not161DOI
KeywordsQUALITY-OF-LIFE; TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; MALIGNANT GLIOMA; CLINICAL-TRIALS; FACTOR RECEPTOR; PSEUDOPROGRESSION; BEVACIZUMAB; ANGIOGENESIS; antitumor activity and safety; glioblastoma; molecular markers; quality of life; sunitinib
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgUnknown
Item ID29406

Export bibliographical data

Owner only: item control page

nach oben